Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Shares

18 Jan 2008 12:53

Oxford Biomedica PLC18 January 2008 For immediate release 18 January 2008 OXFORD BIOMEDICA PLC TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( Yes ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Prudential plc group of companies 4. Full name of shareholder(s) (if different from 3.) (iv): Prudential plc (parent company) M&G Group Limited (wholly owned subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited) The Prudential Assurance Company Limited (wholly owned subsidiary of Prudentialplc) 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 16 January 2008 6. Date on which issuer notified: 18 January 2008 7. Threshold(s) that is/are crossed or reached: 11% 8. Notified details: A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering transaction (vi)using the ISIN CODE Number of shares Number of voting Rights (viii) GB0006648157 58,927,308 58,927,308 Resulting situation after the triggering transaction (vii)Class/type of shares if Number of shares Number of voting rights (ix) % of voting rightspossible using the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect GB0006648157 59,097,037 59,097,037 11.00% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rightsfinancial (xiii) Period/Date (xiv) that may be acquired if theinstrument instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 59,097,037 11.00% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Registered Holder Holding % Prudential plc Total Notifiable Interest 59,097,037 11.00% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 32,912,027 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 7,176,026 M&G Group Limited 59,097,037 11.00% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 32,912,027 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 7,176,026 M&G Investment Management Limited 58,962,421 10.97% Nortrust Nominee Ltd A/C MKK01 32,912,027 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 7,176,026 M&G Limited 59,097,037 11.00% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 32,912,027 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 7,176,026 M&G Securities Limited 33,046,643 6.15% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 32,912,027 The Prudential Assurance Company Limited 25,926,394 4.82% PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 7,176,026 Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 20157:00 amRNSTotal Voting Rights
23rd Feb 20153:36 pmRNSChief Secretary to the Treasury visits OXB
16th Feb 201511:41 amRNSChange of Registered Address
30th Jan 201510:47 amRNSTotal Voting Rights
28th Jan 20154:40 pmRNSSecond Price Monitoring Extn
28th Jan 20154:35 pmRNSPrice Monitoring Extension
31st Dec 20147:00 amRNSBLOCK LISTING RETURN
31st Dec 20147:00 amRNSTotal Voting Rights
18th Dec 20142:45 pmRNSDirector's Share Purchase.
18th Dec 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16th Dec 20143:50 pmRNSDirector PDMR Shareholding
16th Dec 20143:50 pmRNSNotification Of Major Interest In Shares
1st Dec 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
28th Nov 20147:00 amRNSTotal Voting Rights
26th Nov 20147:00 amRNSDirector Dealings
3rd Nov 20147:00 amRNSInterim Management Statement
31st Oct 20147:00 amRNSTotal Voting Rights
17th Oct 20149:27 amRNSDirector's Interest in Share Options
17th Oct 20149:10 amRNSHolding(s) in Company
16th Oct 20144:52 pmRNSDirectorate Change
15th Oct 20145:05 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
13th Oct 20147:00 amRNSOxford BioMedica Acquires Windrush Court Office
10th Oct 20147:41 amRNSAdditional Listing
10th Oct 20147:00 amRNSSecond major agreement with Novartis
28th Aug 20147:00 amRNSHalf Yearly Report
15th Aug 20147:00 amRNSPaul Blake Appointed as Chief Development Officer
7th Aug 20147:00 amRNSNotice of Results
25th Jul 20149:48 amRNSBlock listing Application
1st Jul 201410:55 amRNSOxford BioMedica plc Director's Share Purchase
30th Jun 20147:00 amRNSTotal Voting Rights Update
23rd Jun 20147:00 amRNSDirectors' Interest in Share Options
20th Jun 20142:38 pmRNSPiper Jaffray GenomeRx Symposium in New York
19th Jun 20149:50 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:01 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:00 amRNSGRANT OF AWARDS
18th Jun 201411:30 amRNSLoan Repayment in Full
18th Jun 20149:36 amRNSHolding(s) in Company
18th Jun 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jun 201412:29 pmRNSRESULT OF GENERAL MEETING AND DIRECTORS DEALING
16th Jun 20147:00 amRNSResults of firm fundraising and open offer
3rd Jun 201412:34 pmRNSResult of AGM
29th May 20144:52 pmRNSNotice of posting of prospectus
29th May 20147:00 amRNSFundraising and Open Offer
22nd May 20149:22 amRNSDirector Declaration
13th May 20147:00 amRNSInterim Management Statement
2nd May 20144:57 pmRNS2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30th Apr 20147:00 amRNS£2.2 Million Grant Received from TSB
29th Apr 20147:00 amRNSOxford BioMedica provides update on RetinoStat®
10th Apr 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.